News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
Friday, November 22, 2024Novartis announced an upgrade to its midterm guidance in advance of its Meet Novartis Management event for investors and analysts in London Previous guidance for sales CAGR was upgraded to driven by strong momentum of inmarket growth
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
Thursday, November 21, 2024andMe Holding Co a leading human genetics and preventive health company and Mirador Therapeutics a nextgeneration precision medicine company focused on developing firstinclass or bestinclass therapeutics for immunology and inflammation IIrelated dise...
Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency
Thursday, November 21, 2024Capricor Therapeutics a biotechnology company developing transformative cell and exosomebased therapeutics for the treatment of rare diseases today announced that the European Medicines Agency EMA has granted both Orphan Drug and Advanced Therapy Med...
Steritas Announces Collaboration with argenx to Advance Evidence for Novel Steroid-sparing Therapeutics
Wednesday, November 20, 2024Steritas LLC a company dedicated to enhancing care for steroidtreated patients today announced a licensing agreement with argenx a global immunology company for use of its STOX Suite of steroidtoxicity clinical outcome assessments COAs across argenx
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
Wednesday, November 20, 2024GeneDx a leader in delivering improved health outcomes through genomic insights today announced GeneDx Discover a firstofitskind data visualization tool which provides biopharmaceutical companies access to deidentified and aggregated genetic data po...
Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
Tuesday, November 19, 2024Trogenix Ltd today emerged from stealth mode to unveil its groundbreaking therapeutic platform for treating aggressive cancers Built from inception by BIO Capital which specialises in creating breakthrough therapeutic companies Trogenix spun out from...
Curium Completes Enrollment Early of Phase 3 SOLAR-RECUR Prostate Cancer Trial
Tuesday, November 19, 2024Curium a world leader in nuclear medicine announced that it has completed enrollment of its Phase SOLARRECUR clinical trial The trial is a multicenter openlabel study to evaluate the diagnostic performance of copper Cu PSMA IT PETCT in men with su...
LIfT BioSciences expands into Ireland for manufacturing & clinical operations
Monday, November 18, 2024LIfT BioSciences a rapidly emerging biotech company preparing to start clinical trials for its firstinclass allogeneic innate cell therapy today announces the expansion of its manufacturing and clinical operations with the opening of a new subsidiary...
Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
Saturday, November 16, 2024Sandoz the global leader in generic and biosimilar medicines today announced that the European Commission EC has granted marketing authorization for Afqlir aflibercept mg vial kit and prefilled syringe for intravitreal injection a biosimilar to refe...
Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio
Friday, November 15, 2024Akari Therapeutics Plc announces the completion of the merger the Merger of Akari Therapeutics Plc the Company and Peak Bio Inc Peak Bio creating an innovative biotechnology company with a broader focus in the advancement of multiple disease therapie...
